BioStock Studio:Xintela’s chairman about the company’s journey

Gregory Batcheller has been the chairman of biopharma Xintela since 2011. During this time he has seen the company reach several milestones and now has two ongoing clinical phase I/IIa studies with XSTEM. Batcheller visited BioStock’s studio to tell us more about the company’s journey and business development. 

See the interview at biostock.se:

https://www.biostock.se/en/2023/03/xintelas-chairman-about-the-companys-journey/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/